Skip to main content

Day: November 18, 2021

Stellantis to Host Software Day 2021 on December 7

Stellantis to Host Software Day 2021 on December 7 AMSTERDAM, November 18, 2021 – Stellantis N.V. (NYSE / MTA / Euronext Paris: STLA) (“Stellantis”) announced today it will host Software Day 2021 on Tuesday, December 7, 2021 at 4:00 p.m. CET / 10:00 a.m. EST. Carlos Tavares, Chief Executive Officer, will share Stellantis’ software strategy for fully connected, clean, safe, personalized and affordable mobility that fits seamlessly into customers’ lives, magnifying our 14 iconic brands. Details for accessing the event are available under the Investors section of the Stellantis corporate website at www.stellantis.com. A recorded replay will be accessible under the Investors section of the Stellantis corporate website after the event. About Stellantis Stellantis is one of the world’s leading automakers and a mobility provider, guided...

Continue reading

New York State Approves Precipio’s HemeScreen for POL clinical use

New York Cancer & Blood POL will commence the use of HemeScreen in its laboratory NEW HAVEN, Conn., Nov. 18, 2021 (GLOBE NEWSWIRE) — Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that its HemeScreen RUO assay has received the required approval from New York State’s Department of Health (NY DOH). Hemescreen can now be used by New York based physician-owned laboratories (POLs) who apply to run HemeScreen in their lab as a laboratory-developed test (LDT). New York State’s DOH is considered one of the strictest regulatory bodies in the US; laboratories interested in setting up and running new assays must submit comprehensive validation data demonstrating the accuracy, efficacy, reliability, and reproducibility of those assays. New York State’s DOH conducts an in-depth, rigorous analytical review...

Continue reading

AVVAA World Health Care Products, Inc. (OTC: AVVH) Announces Shareholder Updates

Proposed Dates for Merger and Recent Company Activities Houston, TX, Nov. 18, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — AVVAA World Health Care Products, Inc. (OTC PINK: AVVH) provides shareholder updates for the following recent company activities. Mr. Miguel Sanchez, CEO, states, “We have successfully integrated our new management team into our company infrastructure and will continue to add new key executives in the coming months. During the past 60 days, we have finalized the company strategy to focus as the funder of choice for highly collateralized real estate first lien notes and real estate investments sourced and originated by the Gold Quest Group, LLC.  The company also plans to fund loans with other real estate brokers that provide opportunities that meet the company’s established funding criteria. Our management...

Continue reading

Else to Expand Sales into Europe with Amazon

VANCOUVER, British Columbia, Nov. 18, 2021 (GLOBE NEWSWIRE) — ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) (“Else” or the “Company”) the plant-based baby, toddler and children nutrition company, is pleased to report on its Amazon progress and plans: Following its stellar success on Amazon in the US, Else was recently invited by Amazon EU to launch a European unified account that will allow Else to sell its unique products on all of Amazon European marketplaces including the UK, Germany, France, Italy, Spain, the Netherland, and Sweden representing a market with over 300M people. Else already started the onboarding process with Amazon’s support and plans to launch its first European market in early 2022. “We’re very excited by this opportunity offered by Amazon EU,” said Hamutal Yitzhak, CEO &...

Continue reading

Big Data – Wikisoft’s Big Vision

SAN FRANCISCO, CA, Nov. 18, 2021 (GLOBE NEWSWIRE) — Wikisoft Corp. (the “Company,” “we,” and “our”) (OTCQB: WSFT) — In 2017, the fledgling Wikisoft had a big vision – help businesses large and small in a big way. Our founders’ goal was to create a company information database and then share the information to help small companies grow big. Since then, the company has grown, added world class executives to the C-level team and invested heavily into Big Data technology to fulfill the founders’ vision. It seems the strategy was well-chosen. Here are three facts to justify it: The global big data technology market size was $41.33 billion in 2019 and is projected to reach $116.07 billion by 2027, at a CAGR of 14.0% in forecast period according to a report published by Fortune Business Insights,...

Continue reading

L.B. Foster to Host Virtual Investor Day on December 14th, 2021

PITTSBURGH, Nov. 18, 2021 (GLOBE NEWSWIRE) — L.B. Foster Company (NASDAQ: FSTR) and Investor Relations firm, Lytham Partners will host a Virtual Investor Day on December 14th, 2021, starting at 11:00 a.m. Eastern Time. John Kasel, President and Chief Executive Officer, Bill Thalman, Senior Vice President and Chief Financial Officer, and other members of the senior management team will provide an in-depth review of the Company’s business and growth strategies, including innovation through new products and technology. A live webcast of the presentations, including a Q&A section, will be available the day of the event through L.B. Foster’s Investor Relations Page. Registration for the event is required and can be completed in advance on the Investor Day 2021 Registration Site. If you would like to submit questions prior to the...

Continue reading

Kaltura Extends Longstanding Go-To-Market Relationship With AWS

Kaltura’s primary cloud provider, AWS, fuels the rapid growth of the Kaltura Video Experience Cloud NEW YORK, Nov. 18, 2021 (GLOBE NEWSWIRE) — Today, Kaltura (NASDAQ: KLTR), the Video Experience Cloud, announced that it is extending its longstanding work with Amazon Web Services, Inc. (AWS) as its primary cloud provider to support its rapid growth, leveraging the breadth and depth of AWS services including compute, storage, network & content delivery, analytics, containers, and media services. As part of this announcement, Kaltura shares that it has joined the AWS Independent Software Vendor (ISV) Accelerate Program. As a member of the AWS ISV Accelerate Program, Kaltura is able to co-sell with the AWS Sales organization to accelerate sales cycles and drive new business. Following its acceptance into the AWS ISV Accelerate...

Continue reading

Smokefree Innotec, Inc. (SFIO) Exhibits Rapid Growth through Strategic Acquisitions in Q3 Report

HAMILTON, New Zealand, Nov. 18, 2021 (GLOBE NEWSWIRE) — Smokefree Innotec, Inc. (OTC: SFIO), a leading asset management company and innovation group, is pleased to share news of its recent strategic acquisitions in line with its five-year roadmap of global expansion in the fields of franchising, food manufacturing and distribution, coffee, property development, and technology and software development. ______________________________________ Jeths Lacson, CEO / Chairman, shared the following letter regarding the company’s Q3 report: “Dear shareholders and valued business partners, In the last letter I addressed to you, I outlined a number of projects we had in development for Smokefree Innotec, Inc (SFIO). I am thrilled to share that we have not only accomplished many of the key milestones we had set for the Company since then, but...

Continue reading

Silo Pharma and Strategic Partner Zylo Therapeutics Begin Development Process for Novel Ketamine Loaded Z-Pods

Englewood Cliffs NJ, Nov. 18, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (OTCQB: SILO) a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today announced that their joint venture partner Zylo Therapeutics received its first ketamine shipment and initiated loading ketamine into their Z-Pod® transdermal technology. Eric Weisblum, CEO of Silo Pharma stated “The commencement of Novel Ketamine loaded Z-Pods  is a pivotal advancement for administering Ketamine as a therapeutic with the patented Z-Pod® technology.  This important milestone for Silo will help us study the benefits of slow-release transdermal release of Ketamine.  The delivery and loading accelerates the development to deliver Ketamine as a therapeutic and potentially Psilocybin in a time-released or dosage-controlled manner.” About...

Continue reading

BIMI International Medical Inc. Announces Pricing of $7.8 million Private Placement

New York, Nov. 18, 2021 (GLOBE NEWSWIRE) — BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced that it has entered into a Securities Purchase Agreement (the “SPA”) with two institutional investors (the “Holders”) to sell certain senior secured convertible notes of the Company in a private placement in the aggregate principal amount of $7,800,000 in the aggregate original principal amount of $6,500,000, representing an aggregate original issue discount of 20% (the “Convertible Notes”). The Convertible Notes do not bear interest except upon the occurrence of certain events of default. Pursuant to the SPA, the Convertible Notes will be issued to the Holders, together with 4-year warrants to acquire 1,800,000 shares of the Company’s common stock (the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.